Axsome Therapeutics, Inc. SEC filings AXSM

Axsome Therapeutics, Inc. has 672 filings in SEC EDGAR's recent list, going back to Jun 19, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, other events). The company's fiscal year ends on December 31.

Axsome Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations, Other events
Nov 2, 2026 Nov 2, 2026
4 Insider transaction Sep 3, 2026 Sep 3, 2026
144 Notice of proposed sale Sep 3, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations, Other events
Aug 10, 2026 Aug 10, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
144 Notice of proposed sale Aug 6, 2026 —
144 Notice of proposed sale Aug 5, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
8-K Current report
Other events
Jul 15, 2026 Jul 15, 2026
4 Insider transaction Jul 1, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 11, 2026 Jun 10, 2026
144 Notice of proposed sale Jun 11, 2026 —
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
144 Notice of proposed sale Jun 10, 2026 —
144 Notice of proposed sale Jun 10, 2026 —
144 Notice of proposed sale Jun 10, 2026 —
144 Notice of proposed sale Jun 9, 2026 —
8-K Current report
Officer or director change
Jun 9, 2026 Jun 5, 2026
8-K Current report
Shareholder vote results
Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 9, 2026
4 Insider transaction Jun 9, 2026 Jun 9, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
144 Notice of proposed sale Jun 9, 2026 —
144 Notice of proposed sale Jun 9, 2026 —
8-K Current report
Other events
Jun 3, 2026 Jun 3, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 1, 2026 —
144 Notice of proposed sale May 29, 2026 —
4 Insider transaction May 5, 2026 May 4, 2026
144 Notice of proposed sale May 5, 2026 —
144/A Filing May 5, 2026 —
144 Notice of proposed sale May 4, 2026 —
10-Q Quarterly report May 4, 2026 Mar 31, 2026
8-K Current report
Results of operations, Other events
May 4, 2026 May 4, 2026
8-K Current report
Other events
Apr 30, 2026 Apr 30, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Apr 24, 2026
4 Insider transaction Apr 23, 2026 Apr 21, 2026
4 Insider transaction Apr 23, 2026 Apr 21, 2026
4 Insider transaction Apr 23, 2026 Apr 22, 2026
4 Insider transaction Apr 23, 2026 Apr 21, 2026
4 Insider transaction Apr 23, 2026 Apr 21, 2026
4 Insider transaction Apr 23, 2026 Apr 21, 2026
144 Notice of proposed sale Apr 22, 2026 —
8-K Current report
Other events
Apr 1, 2026 Apr 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
144 Notice of proposed sale Feb 26, 2026 —
144 Notice of proposed sale Feb 26, 2026 —
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
10-K Annual report Feb 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 23, 2026 Feb 23, 2026
8-K Current report
Other events
Feb 17, 2026 Feb 17, 2026
4 Insider transaction Feb 10, 2026 Feb 10, 2026
4 Insider transaction Feb 2, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 2, 2026 —
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Jan 2, 2026 Dec 31, 2025
144 Notice of proposed sale Dec 31, 2025 —
8-K Current report
Other events
Dec 31, 2025 Dec 31, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 4, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Nov 5, 2025 —
4 Insider transaction Nov 5, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 4, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
S-3ASR Automatic shelf registration Nov 3, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations, Other events
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Oct 8, 2025 Oct 6, 2025
144 Notice of proposed sale Oct 8, 2025 —
144 Notice of proposed sale Oct 7, 2025 —
144 Notice of proposed sale Oct 6, 2025 —
4 Insider transaction Sep 22, 2025 Sep 22, 2025
144 Notice of proposed sale Sep 22, 2025 —
4 Insider transaction Sep 17, 2025 Sep 16, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
144 Notice of proposed sale Sep 16, 2025 —
144 Notice of proposed sale Sep 16, 2025 —
144 Notice of proposed sale Sep 15, 2025 —
144 Notice of proposed sale Sep 12, 2025 —
4 Insider transaction Sep 9, 2025 Sep 8, 2025
4 Insider transaction Sep 5, 2025 Sep 5, 2025
144 Notice of proposed sale Sep 5, 2025 —
4 Insider transaction Sep 2, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
4 Insider transaction Aug 29, 2025 Aug 27, 2025
144 Notice of proposed sale Aug 29, 2025 —
144 Notice of proposed sale Aug 28, 2025 —
144 Notice of proposed sale Aug 27, 2025 —
4 Insider transaction Aug 26, 2025 Aug 22, 2025
144 Notice of proposed sale Aug 26, 2025 —
144 Notice of proposed sale Aug 22, 2025 —
8-K Current report
Other events
Aug 20, 2025 Aug 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Aug 4, 2025 Aug 4, 2025
4 Insider transaction Jun 23, 2025 Jun 20, 2025
144 Notice of proposed sale Jun 23, 2025 —
144 Notice of proposed sale Jun 20, 2025 —
4 Insider transaction Jun 18, 2025 Jun 16, 2025
144 Notice of proposed sale Jun 18, 2025 —
144 Notice of proposed sale Jun 17, 2025 —
144 Notice of proposed sale Jun 16, 2025 —
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
8-K Current report
Other events
Jun 10, 2025 Jun 10, 2025
8-K Current report
Shareholder vote results
Jun 9, 2025 Jun 6, 2025
144 Notice of proposed sale Jun 9, 2025 —
8-K Current report
Other events
Jun 9, 2025 Jun 9, 2025
4 Insider transaction May 29, 2025 May 27, 2025
4 Insider transaction May 28, 2025 May 27, 2025
144 Notice of proposed sale May 28, 2025 —
144 Notice of proposed sale May 28, 2025 —
144 Notice of proposed sale May 27, 2025 —
144 Notice of proposed sale May 27, 2025 —
8-K Current report
Other events
May 27, 2025 May 27, 2025
4 Insider transaction May 20, 2025 May 20, 2025
144 Notice of proposed sale May 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
May 13, 2025 May 8, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations, Other events
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Apr 25, 2025
8-K Current report
Other events
Apr 1, 2025 Apr 1, 2025
8-K Current report
Other events
Mar 25, 2025 Mar 25, 2025
8-K Current report
Other events
Mar 5, 2025 Mar 5, 2025
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
10-K Annual report Feb 18, 2025 Dec 31, 2024
8-K Current report
Results of operations, Other events
Feb 18, 2025 Feb 18, 2025
4 Insider transaction Feb 14, 2025 Feb 13, 2025
144 Notice of proposed sale Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
144 Notice of proposed sale Feb 13, 2025 —
8-K Current report
Other events
Feb 10, 2025 Feb 10, 2025
8-K Current report
Other events
Jan 31, 2025 Jan 30, 2025
8-K Current report
Results of operations, Other events
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
8-K Current report
Other events
Dec 30, 2024 Dec 30, 2024
8-K Current report
Other events
Nov 26, 2024 Nov 26, 2024
4 Insider transaction Nov 20, 2024 Nov 19, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations, Other events
Nov 12, 2024 Nov 12, 2024
3 Initial insider ownership Oct 24, 2024 Oct 14, 2024
8-K Current report
Material agreement
Oct 1, 2024 Sep 30, 2024
4 Insider transaction Sep 11, 2024 Sep 11, 2024
144 Notice of proposed sale Sep 11, 2024 —
8-K Current report
Other events
Sep 4, 2024 Sep 4, 2024
8-K Current report
Other events
Aug 21, 2024 Aug 21, 2024
4 Insider transaction Aug 9, 2024 Aug 9, 2024
144 Notice of proposed sale Aug 9, 2024 —
S-8 Employee stock plan registration Aug 5, 2024 —
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024
4 Insider transaction Jun 11, 2024 Jun 7, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AXSM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1579428

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.